IP Library › Granted Patent US 11,142,787
Granted Patent B2
US 11,142,787 · App. 17/053,622 · Granted Oct 12, 2021

Method for performing single-cell analysis and device therefor

Inventors: Masahito Hosokawa (Tokyo, JP); Haruko Takeyama (Tokyo, JP); Yohei Nishikawa (Tokyo, JP); Masato Kogawa (Tokyo, JP)
Assignee: bitBiome, Inc.
C12Q1/6848B01L3/502792C12N11/04C12N15/10C12N15/1093B01L2200/0652B01L2200/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,142,787
App. No.
17/053,622
Granted
Oct 12, 2021
Kind
B2
Abstract

The present invention provides a genome library production method in which cell lysis and genome amplification are performed using a simple operation. More particularly, the present invention provides a method that is for amplifying polynucleotides in cells and that comprises: a step for using a sample containing two or more cells or cell-like structures, and encapsulating the cells or cell-like structures into droplets, one for each droplet; a step for gelling the droplets to generate gel capsules; a step for performing lysis of the cells or cell-like structures by immersing the gel capsules in one or more types of reagents for lysis so as to cause the polynucleotides in the cells to be eluted in the gel capsules and to be kept in the gel capsules in a state where substances binding to the polynucleotides are removed; and a step for bringing the polynucleotides into contact with a reagent for amplification to amplify the polynucleotides in the gel capsules.

Claims (39)

1. A method of amplifying a polynucleotide in a cell or a cell-like construct, comprising the steps of:

encapsulating two or more cells or cell-like structures in liquid droplets, at one cell or construct unit per liquid droplet, by using a sample comprising the cells or cell-like structures;

converting the liquid droplets into gel to generate a gel capsule;

immersing the gel capsule in one or more types of lysis reagents to lyse the cells or cell-like structures, wherein a polynucleotide in the cells, which has eluted out into the gel capsule, is retained in the gel capsule with a substance binding to the polynucleotide removed; and

contacting the polynucleotide with an amplification reagent to amplify the polynucleotide within the gel capsule while maintaining a gelatinous state.

2. The method of claim 1 , wherein the cells comprise a microbial cell.

3. The method of claim 2 , wherein the lysis reagent comprises lysozyme, achromopeptidase, protease K, sodium dodecyl sulfate, and potassium hydroxide.

4. The method of claim 1 , wherein the lysis reagent and a contaminant are removed from the gel capsule after immersing the gel capsule in the lysis reagent.

5. The method of claim 1 , wherein the liquid droplets encapsulating the cells or cell-like structures are prepared by allowing a suspension of the cells or cell-like structures to flow in a microchannel and shearing the suspension with oil.

6. The method of claim 1 , wherein a diameter of the liquid droplets is 1 to 250 μm.

7. The method of claim 1 , wherein a diameter of the gel capsule is 1 to 250 μm.

8. The method of claim 1 , wherein the gel capsule is formed from agarose, acrylamide, photocurable resin, PEG, gelatin, sodium alginate, matrigel, or collagen.

9. The method of claim 1 , wherein at least one type of the lysis reagent is selected from the group consisting of lysozyme, labiase, yatalase, achromopeptidase, protease, nuclease, zymolyase, chitinase, lysostaphin, mutanolysin, sodium dodecyl sulfate, sodium lauryl sulfate, potassium hydroxide, sodium hydroxide, phenol, chloroform, guanidine hydrochloride, urea, 2-mercaptoethanol, dithiothreitol, TCEP-HCl, sodium cholate, sodium deoxycholate, Triton X-100, Triton X-114, NP-40, Brij-35, Brij-58, Tween 20, Tween 80, octyl glucoside, octyl thioglucoside, CHAPS, CHAPSO, dodecyl-β-D-maltoside, Nonidet P-40, and Zwittergent 3-12.

10. The method of claim 1 , wherein the gel capsule is a hydrogel capsule.

11. The method of claim 1 , wherein the step of amplifying is performed by an isothermal strand displacement amplification reaction.

12. The method of claim 1 , wherein a gel liquid droplet shape is maintained in the amplification step.

13. The method of claim 1 , wherein the state wherein the substance binding to the polynucleotide is removed is a state where a DNA binding protein is removed.

14. The method of claim 1 , further comprising the step of sequencing a nucleic acid sequence in the amplified polynucleotide.

15. A method of preparing a genome library, comprising the step of sorting, separating, and collecting each gel capsule with the polynucleotide amplified by the method of claim 1 .

16. A method of genome sequencing of a cell at a single-cell level, comprising the step of genomic DNA sequencing of the cell from a polynucleotide amplified by the method of claim 1 .

17. A method of genome sequencing of a cell at a single-cell level, comprising the steps of:

encapsulating two or more cells or cell-like structures in liquid droplets, at one cell or construct unit per liquid droplet, by using a sample comprising the cells or cell-like structures;

converting the liquid droplets into gel to generate a gel capsule;

immersing the gel capsule in one or more types of lysis reagents to lyse the cells or cell-like structures, wherein a polynucleotide in the cells, which has eluted out into the gel capsule, is retained in the gel capsule with a substance binding to the polynucleotide removed;

contacting the polynucleotide with an amplification reagent to amplify the polynucleotide within the gel capsule while maintaining a gelatinous state; and

determining a whole sequence of a genomic DNA of the cells from the amplified polynucleotide,

wherein the cells comprise a microbial cell,

wherein the lysis reagent comprises lysozyme, achromopeptidase, protease K, sodium dodecyl sulfate, and potassium hydroxide;

wherein the state where the substance binding to the polynucleotide is removed is a state where a DNA binding protein is removed, and

wherein the amplification step is performed by an isothermal strand displacement amplification reaction.

18. A device for amplifying a polynucleotide in a cell, comprising:

a liquid droplet preparation unit for encapsulating cells or cell-like structures in liquid droplets at one cell or construct unit per liquid droplet;

a gel capsule generation unit for converting the liquid droplets into gel to generate a gel capsule;

a lysis reagent immersion unit for immersing the gel capsule in a lysis reagent, wherein the lysis reagent immersion unit is configured so that a polynucleotide in the cells, which has eluted out into the gel capsule, is retained in the gel capsule, with a substance binding to the polynucleotide removed, upon lysis;

a removal unit for removing a contaminant from the gel capsule; and

an amplification reagent immersion unit for immersing the gel capsule in an amplification reagent, wherein the amplification reagent immersion unit is configured so that a gelatinous state is maintained for the gel capsule during amplification.

19. The device of claim 18 further characterized in genome sequencing of a cell at a single-cell level, further comprising a sequencing unit for sequencing a nucleic acid sequence in a polynucleotide amplified by the amplification reagent immersion unit.

20. The device of claim 18 further characterized in preparing a genome library, further comprising a sorting unit for sorting the gel capsule and housing the gel capsule in a housing container.

21. The device of claim 18 , wherein the liquid droplet preparation unit comprises a microchannel.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2020
From: HOSOKAWA, MASAHITO; TAKEYAMA, HARUKO; NISHIKAWA, YOHEI; KOGAWA, MASATO
To: BITBIOME, INC.
Reel/Frame 054424/0420 →
Priority Claims (1)
JP JP2018-089259 · May 7, 2018 · national
Continuity (1)
Related Publication 20210246495A1 · Aug 12, 2021
Cited By (6)
US 12,553,819 US 12,569,847 US 12,576,399 US 12,576,400 US 12,661,647 US 12,714,996